A Dialysis Duopoly: How Public Funding Entrenched Private Power

Fumika Mizuno is a third-year law student at Yale Law School.

PUBLISHED 07.08.25

For the half-million people in the U.S. with kidney failure, survival rests in the hands of two powerful corporations—DaVita and Fresenius. Together, these companies control over 70% of the outpatient dialysis market. But the history of dialysis isn’t a simple narrative of corporate consolidation; it’s a case study of how public funding can entrench private power in health care, and the detrimental effects this has on care quality and cost.

https://lpeproject.org/blog/a-dialysis-duopoly-how-public-funding-entrenched-private-power/

TL;DR For-profit Kidney dialysis centers lobby congress to suppress funding for cures, but get Medicare funding for dialysis. It is more money laundering.

Anon's Comments: Patients are literally being milked for profit after being rejected for transplant for any number of bullshit excuses. Not complying to their vaccine mandates (that's all the vaccines, not just covid) is one. It doesn't matter what they say. They will make up something if their policy is that vaccines are optional, and the transplant team don't like you for thinking. Not everyone is in kidney failure from diabetus and obesity. Other causes include vaccine damage known as "low grade infection that you didn't see the doctor for" and these are not admitted to. The reason there are no "cures" or ways to get off the machine other than transplant, is because the funding isn't there, and that is a result of lobbying done by Davita and Fresenius. This money-machine has to end. POTUS can sign all the EOs for kidneyX that he wants to. Nothing will come of it.